Trials / Unknown
UnknownNCT04436224
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation: A Dose-exploration and Effectiveness Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 530 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hydromorphone has a clear analgesic effect, and has few advantages in respiratory depression and gastrointestinal motility. The study will further explore the continuous pumping-dose of hydromorphone for ICU non-mechanical ventilation patients and monitor its effective plasma concentration as well as evaluates the safety and effectiveness of hydromorphone for ICU non-mechanical ventilation patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydromorphone | Intravenous analgesia using hydromorphone in ICU patients with non-mechanical ventilation(NS 40ML+ hydromorphone 10mg ,IV-Pump) |
| DRUG | Fentanyl | Intravenous analgesia using fentanyl in ICU patients with non-mechanical ventilation(NS 40ML+ fentanyl 0.5mg, IV-Pump) |
| DRUG | Butorphanol | Intravenous analgesia using butorphanol in ICU patients with non-mechanical ventilation(NS 40ML+ butorphanol 10mg,IV-Pump) |
Timeline
- Start date
- 2020-09-04
- Primary completion
- 2022-06-01
- Completion
- 2022-09-01
- First posted
- 2020-06-17
- Last updated
- 2022-01-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04436224. Inclusion in this directory is not an endorsement.